Pre-Clinical Rationale for Amcenestrant Combinations in HER2+/ER+ Breast Cancer

Amira F. Mahdi, Niall Ashfield, John Crown, Denis M. Collins

Open source

DOI
10.3390/ijms26020460
Published
2025-01-08
Container
International Journal of Molecular Sciences
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ijms26020460,
  title = {Pre-Clinical Rationale for Amcenestrant Combinations in HER2+/ER+ Breast Cancer},
  author = {Amira F. Mahdi and Niall Ashfield and John Crown and Denis M. Collins},
  year = {2025},
  journal = {International Journal of Molecular Sciences},
  doi = {10.3390/ijms26020460},
  url = {https://doi.org/10.3390/ijms26020460}
}

RIS

TY  - JOUR
TI  - Pre-Clinical Rationale for Amcenestrant Combinations in HER2+/ER+ Breast Cancer
AU  - Amira F. Mahdi
AU  - Niall Ashfield
AU  - John Crown
AU  - Denis M. Collins
PY  - 2025
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms26020460
UR  - https://doi.org/10.3390/ijms26020460
ER  - 

APA

Mahdi, A. F., Ashfield, N., Crown, J., & Collins, D. M. (2025). Pre-Clinical Rationale for Amcenestrant Combinations in HER2+/ER+ Breast Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26020460

Source records